Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sexually Transmitted Diseases

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 12 articles: HTML format

Single Articles

January 2023
1. LANDY R, Haber G, Graubard BI, Campos NG, et al
   Upper age-limits for US male HPV-vaccination for oropharyngeal cancer prevention: A microsimulation-based modeling study.
   J Natl Cancer Inst. 2023 Jan 19:djad009. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2022
2. KREIMER AR, Cernuschi T, Rees H, Brotherton JML, et al
   Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule.
   J Natl Cancer Inst. 2022 Oct 4. pii: 6747964. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2022
3. HU SY, Kreimer AR, Porras C, Guillen D, et al
   Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial.
   J Natl Cancer Inst. 2022 May 31. pii: 6596052. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. LALONDE CS, Teng Y, Burtness BA, Ferris RL, et al
   The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.
   J Natl Cancer Inst. 2022 May 14. pii: 6585900. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2022
5. HUEPENBECKER SP, Meyer LA
   How Can We Pursue Equity in Cervical Cancer Prevention with Existing HPV Genotype Differences?
   J Natl Cancer Inst. 2022 Feb 17. pii: 6530293. doi: 10.1093.
   PubMed    
   
   
   
6. MIX J, Saraiya M, Hallowell BD, Befano B, et al
   Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
   J Natl Cancer Inst. 2022 Feb 17. pii: 6530292. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2021
7. CORREDOR G, Toro P, Koyuncu C, Lu C, et al
   An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients with HPV-Associated Oropharyngeal Cancer.
   J Natl Cancer Inst. 2021 Nov 29. pii: 6446037. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2021
8. DEHLENDORFF C, Baandrup L, Kjaer SK
   Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
   J Natl Cancer Inst. 2021;113:869-874.
   PubMed     Abstract available
   
   
   June 2021
9. BURTNESS B, Contessa J
   Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
   J Natl Cancer Inst. 2021;113:652-653.
   PubMed    
   
   
   
10. DESHMUKH AA, Suk R, Shiels MS, Damgacioglu H, et al
    Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
    J Natl Cancer Inst. 2021;113:792-796.
    PubMed     Abstract available
    
    
    April 2021
11. CAMPOS NG, Chaturvedi AK, Kreimer AR
    Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227604. doi: 10.1093.
    PubMed    
    
    
    
12. KJAER SK, Dehlendorff C, Belmonte F, Baandrup L, et al
    Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227603. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: